Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Other financing activities (2023 - 2025)

Historic Other financing activities for Mereo BioPharma (MREO) over the last 3 years, with Q2 2025 value amounting to $134000.0.

  • Mereo BioPharma's Other financing activities fell 3881.28% to $134000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $239000.0, marking a year-over-year decrease of 8148.72%. This contributed to the annual value of $853000.0 for FY2024, which is 6692.76% up from last year.
  • According to the latest figures from Q2 2025, Mereo BioPharma's Other financing activities is $134000.0, which was down 3881.28% from $65000.0 recorded in Q1 2025.
  • In the past 5 years, Mereo BioPharma's Other financing activities registered a high of $594000.0 during Q3 2024, and its lowest value of $40000.0 during Q4 2024.
  • For the 3-year period, Mereo BioPharma's Other financing activities averaged around $255000.0, with its median value being $176500.0 (2024).
  • As far as peak fluctuations go, Mereo BioPharma's Other financing activities tumbled by 9163.18% in 2024, and later crashed by 3881.28% in 2025.
  • Quarter analysis of 3 years shows Mereo BioPharma's Other financing activities stood at $478000.0 in 2023, then tumbled by 91.63% to $40000.0 in 2024, then surged by 235.0% to $134000.0 in 2025.
  • Its last three reported values are $134000.0 in Q2 2025, $65000.0 for Q1 2025, and $40000.0 during Q4 2024.